AAN Summer Conference

Supported by a team of world-renowned leaders in the field of autoimmune neurology, Mayo Clinic Laboratories’ testing for immune-mediated neurological disorders is unparalleled. Driven by ongoing discoveries about the role of autoantibody biomarkers in autoimmune neurologic disease, our lab continually validates novel autoantibody profiles that inform clinical decision-making. With evaluations that span the spectrum of autoimmune neurological disorders, our testing enables insights on diagnosis, prognosis, disease management, and treatment efficacy.

Resources

Videos, webinars, podcasts, and Hot Topics

The Power of Discovery

Autoimmune encephalopathy evaluation: Why be comprehensive?

Neuroimmunology: Updates and antibody test utilization

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score

Pediatric Autoimmune CNS Disorders Evaluation

Advancements in Autoimmune Neurology: Dr. Andrew McKeon

Communique, Case Study, and Patient Spotlight

Nailing the suspect: The prevalence of autoimmune encephalitis compared with infectious encephalitis

University of Louisville: Building an evidence-based algorithm to guide autoimmune neurology patient care

Back from the brink: Sheila Lewis

Printable documents

APE2 Scorecard

Antibody Matrix

Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations Study

Test Request Form

Contact us